Cargando…

lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis

Detalles Bibliográficos
Autores principales: Xiang, Yuan, Zong, Qi‐Bei, Liu, Hui, Li, Han‐Ning, Wu, Qi‐Fang, Dai, Zhou‐Tong, Huang, You, Shen, Chao, Li, Le‐Wei, Li, Xing‐Rui, Liao, Xing‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111635/
https://www.ncbi.nlm.nih.gov/pubmed/37070231
http://dx.doi.org/10.1002/ctm2.1240
_version_ 1785027486447304704
author Xiang, Yuan
Zong, Qi‐Bei
Liu, Hui
Li, Han‐Ning
Wu, Qi‐Fang
Dai, Zhou‐Tong
Huang, You
Shen, Chao
Li, Le‐Wei
Li, Xing‐Rui
Liao, Xing‐Hua
author_facet Xiang, Yuan
Zong, Qi‐Bei
Liu, Hui
Li, Han‐Ning
Wu, Qi‐Fang
Dai, Zhou‐Tong
Huang, You
Shen, Chao
Li, Le‐Wei
Li, Xing‐Rui
Liao, Xing‐Hua
author_sort Xiang, Yuan
collection PubMed
description
format Online
Article
Text
id pubmed-10111635
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101116352023-04-19 lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis Xiang, Yuan Zong, Qi‐Bei Liu, Hui Li, Han‐Ning Wu, Qi‐Fang Dai, Zhou‐Tong Huang, You Shen, Chao Li, Le‐Wei Li, Xing‐Rui Liao, Xing‐Hua Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2023-04-17 /pmc/articles/PMC10111635/ /pubmed/37070231 http://dx.doi.org/10.1002/ctm2.1240 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Xiang, Yuan
Zong, Qi‐Bei
Liu, Hui
Li, Han‐Ning
Wu, Qi‐Fang
Dai, Zhou‐Tong
Huang, You
Shen, Chao
Li, Le‐Wei
Li, Xing‐Rui
Liao, Xing‐Hua
lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title_full lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title_fullStr lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title_full_unstemmed lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title_short lncRNA IGF2‐AS regulates miR‐500a‐3p/PPP4R1/p‐VEGFR2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
title_sort lncrna igf2‐as regulates mir‐500a‐3p/ppp4r1/p‐vegfr2 signalling pathway to promote thyroid carcinoma progression and tubulogenesis
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111635/
https://www.ncbi.nlm.nih.gov/pubmed/37070231
http://dx.doi.org/10.1002/ctm2.1240
work_keys_str_mv AT xiangyuan lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT zongqibei lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT liuhui lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT lihanning lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT wuqifang lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT daizhoutong lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT huangyou lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT shenchao lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT lilewei lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT lixingrui lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis
AT liaoxinghua lncrnaigf2asregulatesmir500a3pppp4r1pvegfr2signallingpathwaytopromotethyroidcarcinomaprogressionandtubulogenesis